These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1295542)

  • 1. Antiplasmid activity: loss of bacterial resistance to antibiotics.
    Molnár J; Földeák S; Nakamura MJ; Rausch H; Domonkos K; Szabó M
    APMIS Suppl; 1992; 30():24-31. PubMed ID: 1295542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplasmid activity of tricyclic compounds.
    Molnár J
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):467-74. PubMed ID: 3047509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor induction in tobacco by Agrobacterium tumefaciens and nodulation induced by Rhizobium meliloti in the presence of phenothiazines and structurally related compounds.
    Szabo M; Molnar J; Bánfalvi Z; Motohashi N
    Anticancer Res; 1992; 12(5):1667-70. PubMed ID: 1444234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial effect, plasmid curing activity and chemical structure of some tricyclic compounds.
    Molnár J; Mándi Y; Holland IB; Schneider G
    Acta Microbiol Acad Sci Hung; 1977; 24(1):1-6. PubMed ID: 22219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplasmid activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
    Motohashi N; Sakagami H; Kurihara T; Csuri K; Molnar J
    Anticancer Res; 1992; 12(1):135-9. PubMed ID: 1567159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplasmid activity of 1'-acetoxychavicol acetate from Alpinia galanga against multi-drug resistant bacteria.
    Latha C; Shriram VD; Jahagirdar SS; Dhakephalkar PK; Rojatkar SR
    J Ethnopharmacol; 2009 Jun; 123(3):522-5. PubMed ID: 19501283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of plasmid curing in bacteria.
    Spengler G; Molnár A; Schelz Z; Amaral L; Sharples D; Molnár J
    Curr Drug Targets; 2006 Jul; 7(7):823-41. PubMed ID: 16842214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between tricyclic psychopharmacons and some antibiotics.
    Molnár J; Bathó N; Csík V; Chevalier J; Cremieux A
    Acta Microbiol Immunol Hung; 1995; 42(3):277-85. PubMed ID: 8548201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of tricyclic drugs on Escherichia coli and Yersinia enterocolitica plasmid maintenance and replication.
    Csiszar K; Molnar J
    Anticancer Res; 1992; 12(6B):2267-72. PubMed ID: 1295474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of plasmid curing by 9-aminoacridine and two phenothiazines in the presence of proton pump inhibitor 1-(2-benzoxazolyl)-3,3,3-trifluoro-2-propanone.
    Spengler G; Miczák A; Hajdú E; Kawase M; Amaral L; Molnár J
    Int J Antimicrob Agents; 2003 Sep; 22(3):223-7. PubMed ID: 13678825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial & antiplasmid activities of Helicteres isora L.
    Shriram V; Jahagirdar S; Latha C; Kumar V; Dhakephalkar P; Rojatkar S; Shitole MG
    Indian J Med Res; 2010 Jul; 132():94-9. PubMed ID: 20693597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (3H)-imipramine binding and plasmid replication sites in Escherichia coli.
    Molnár J; Csiszár K; Tóth G
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):127-37. PubMed ID: 6342080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence associated plasmid and R-plasmid curing in Yersinia enterocolitica by some tricyclic compounds.
    Molnár J; Nakamura MJ
    Acta Microbiol Hung; 1988; 35(3):307-12. PubMed ID: 2465656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious plasmid resistance and efflux pump mediated resistance.
    Molnár J; Molnár A; Spengler G; Mándi Y
    Acta Microbiol Immunol Hung; 2004; 51(3):333-49. PubMed ID: 15571073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-receptor interaction on plasmid elimination by phenothiazines and imipramine in Escherichia coli.
    Molnár J; Mándi Y; Földeák S
    Acta Microbiol Acad Sci Hung; 1982; 29(1):17-25. PubMed ID: 7046353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
    Motohashi N; Sakagami H; Kurihara T; Ferenczy L; Csuri K; Molnar J
    Anticancer Res; 1992; 12(4):1207-10. PubMed ID: 1503410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bacterial plasmid replication by stereoselective binding by tricyclic psychopharmacons.
    Molnár J; Gálfi M; Lózsa A; Nakamura MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):235-49. PubMed ID: 6369455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of cannabispiro compounds and tetrahydrocannabidiolic acid on the plasmid transfer and maintenance in Escherichia coli.
    Molnár J; Csiszár K; Nishioka I; Shoyama Y
    Acta Microbiol Hung; 1986; 33(3):221-31. PubMed ID: 3551476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.